Almenoff June Sherie
SEC insider (Form 3/4/5 filer). CIK 0001492647. Director at Actinium Pharmaceuticals, Inc. (ATNM) and 2 other issuers. 14 reported Form 4/5 transactions since Sep 2024; latest on Sep 2, 2026. Located in NEW YORK, NY.
Companies Almenoff June Sherie has filed insider reports for
- Actinium Pharmaceuticals, Inc. (ATNM): Director
- TENAX THERAPEUTICS, INC. (TENX): Director
- Avalo Therapeutics, Inc. (AVTX): Director
Almenoff June Sherie
CIK: 0001492647
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Sep 2, 2026ATNM
Actinium Pharmaceuticals, Inc.
AwardDirect18K shares- - Jan 9, 2026TENX
TENAX THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
30K shares- - Nov 18, 2025TENX
TENAX THERAPEUTICS, INC.
PurchaseIndirect1.9K shares at avg. $7.52$14K - Nov 18, 2025TENX
TENAX THERAPEUTICS, INC.
PurchaseDirect1.9K shares at avg. $7.52$14K - Nov 17, 2025TENX
TENAX THERAPEUTICS, INC.
PurchaseIndirect93 shares at avg. $7.15$664.95 - Nov 17, 2025TENX
TENAX THERAPEUTICS, INC.
PurchaseDirect93 shares at avg. $7.15$664.95 - Jul 1, 2025TENX
TENAX THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
80K shares- - Jun 17, 2025AVTX
Avalo Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
20.1K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
50K shares- - Mar 28, 2025AVTX
Avalo Therapeutics, Inc.
ExerciseDirect3.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 2, 2026 |  ATNM Actinium Pharmaceuticals, Inc. | Award | 18,000 | - | $0 | Direct |
| Jan 9, 2026 |  TENX TENAX THERAPEUTICS, INC. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Nov 18, 2025 | TENX TENAX THERAPEUTICS, INC. | Purchase | 1,900 | $7.52 | $14,280 | Indirect |
| Nov 18, 2025 | TENX TENAX THERAPEUTICS, INC. | Purchase | 1,900 | $7.52 | $14,280 | Direct |
| Nov 17, 2025 | TENX TENAX THERAPEUTICS, INC. | Purchase | 93 | $7.15 | $665 | Indirect |
| Nov 17, 2025 | TENX TENAX THERAPEUTICS, INC. | Purchase | 93 | $7.15 | $665 | Direct |
| Jul 1, 2025 | TENX TENAX THERAPEUTICS, INC. | Award Stock Option (right to buy) | 80,000 | - | - | Direct |
| Jun 17, 2025 |  AVTX Avalo Therapeutics, Inc. | Award Stock Option (Right to Buy) | 20,100 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 50,000 | - | - | Direct |
| Mar 28, 2025 | AVTX Avalo Therapeutics, Inc. | Exercise | 3,167 | - | - | Direct |
1-10 of 14 transactions